Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1988-3-18
pubmed:abstractText
The recently described human immunodeficiency virus type 2 (HIV2) is significantly divergent in sequence from the more frequently isolated human immunodeficiency virus type 1 (HIV1). Both HIV1 and HIV2 encode a transactivator that is capable of strongly stimulating expression directed by the viral long terminal repeat (LTR). Here, we define the region of the HIV2 genome encoding the transactivator and show that the specificity of the transactivator differs from that of HIV1. By deletion analysis of the HIV2-LTR, we show that both HIV1 and HIV2 transactivators require sequences within 35 to 53 bp downstream of the start of transcription. However, in order to stimulate expression at full efficiency, the HIV2 transactivator further requires sequences unique to the HIV2-LTR between nucleotides +53 and +99. Hence, HIV2 poorly transactivates the LTR of HIV1, while two divergent isolates of HIV1 will efficiently transactivate the LTR of either HIV1 or HIV2. Nonetheless, in vivo competition between the transactivators of HIV1 and HIV2 suggests that they use a common mechanism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2420471, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2423703, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2424612, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2432602, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2981427, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2981635, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2990040, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2990041, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-2994217, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3002031, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3003584, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3007995, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3019563, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3025743, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3025848, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3031510, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3031512, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3033826, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3039372, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3159089, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3472076, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3490693, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3491989, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3530501, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3638988, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3643816, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3646094, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3649576, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-3907859, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-4705382, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-6757864, http://linkedlifedata.com/resource/pubmed/commentcorrection/2828036-6960240
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0261-4189
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3755-60
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.
pubmed:affiliation
Unité d'Oncologie Viral (CNRS UA 1157), Institut Pasteur, Paris, France.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't